Image: Kubow & Iskandor 2022
Unfortunately, it seems that, even in the case where someone has “good metabolic health” when assessed by standard metrics (low high-density
lipoprotein cholesterol, elevated blood pressure, triglycerides, and fasting plasma glucose), the incidence of Ischemic Heart Disease (IHD) events is still elevated, as well as risk of coronary heart disease, cerebrovascular disease and heart failure, and hence the term “metabolically-healthy-obesity” (MHO) may be quite misleading (Caleyachetty et al. 2017; Hansen et al. 2017). This is especially true for men, as the risk of an IHD event in that study for those with MHO was much higher, and while the risk was still elevated for MHO women, the authors note that it failed to reach statistical significance. The authors also note the impermanence of the MHO phenotype, as a large proportion of
those with an MHO profile at the beginning of the study were no longer considered metabolically healthy at 5 years of follow-up.